⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.
Nuclear Lamina and Progerin in Premature Aging
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-03 — In Vivo Base Editing Partially Rescues Bone Dysplasia in a Mouse Model of Hutchinson‐Gilford Progeria Syndrome: cross-connection with hgps-progeria: Base-editing correction of the LMNA C→T mutation reduces progerin production, directly linking HGPS phenotype rescue to the nuclear lamina/progerin mechanism page. (novelty: 3)
- 2026-07-01 — AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.: 2026 preclinical progeroid mouse study: LM2556, an AI-optimized antisense oligonucleotide against the LMNA 3’UTR, selectively reduced progerin and farnesylated pre-lamin A while sparing lamin C, rescued cardiovascular pathology, and extended median lifespan by ~83% in progeroid mice — first AI-designed ASO proof-of-concept for laminopathies, no human data. [animal-model] (novelty: 4)
Open questions
Related
Contributing findings
AI-driven therapeutic antisense oligonucleotide for processing-deficient progeroid laminopathies.
01-jul-2026
novelty 4
per-area 4
strengthens